🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with HBeAG positive, chronic HBV infection will receive either ARC...
Status
Terminated
Location
Research Site 1
Start Date
2015-11
Trial ID
NCT02604212
Treatments Being Tested
The purpose of this study is to determine whether ARC-520 in combination wi...
Status
Terminated
Location
Research Site 1
Start Date
2014-03
Trial ID
NCT02065336
Treatments Being Tested
Patients with chronic HBV infection will receive either ARC-520 or placebo ...
Status
Terminated
Location
Research Site 1
Start Date
2015-09
Trial ID
NCT02604199
Treatments Being Tested
Patients with chronic HBV infection will receive ARC-520 in combination wit...
Status
Withdrawn
Location
Research Site 1
Start Date
2015-02
Trial ID
NCT02349126
Treatments Being Tested
Participants with chronic HBV infection will receive multiple doses of ARC-...
Status
Terminated
Location
Research Site 1
Start Date
2015-08
Trial ID
NCT02452528
Treatments Being Tested
Patients with chronic HBV infection will receive either ARC-520 alone or AR...
Status
Terminated
Location
Research Site 3
Start Date
2015-12
Trial ID
NCT02577029
Treatments Being Tested
Single doses of ARC-520 will be evaluated at varying infusion rates and by ...
Status
Completed
Location
Research Site 1
Start Date
2015-09
Trial ID
NCT02535416
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Research Site 1
Start Date
2013-07
Trial ID
NCT01872065
Chronic HBV patients will receive 9 doses of open-label ARC-520 once every ...
Status
Terminated
Location
Research Site 1
Start Date
2016-03
Trial ID
NCT02738008
Treatments Being Tested